FDA 483 - Hainan Shuangcheng Pharmaceuticals Co Ltd - April 24, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Hainan Shuangcheng Pharmaceuticals Co., Ltd. in Haikou City, China, revealed significant deficiencies. Observations included inadequate controls over computer systems for user privileges, insufficient environmental monitoring in aseptic processing areas, and a lack of proper training for personnel performing visual inspections. Additionally, procedures to prevent microbiological contamination of sterile drug products were not adequately established or followed.
ID · 61a2c06a-c751-409c-a965-9c86c6672c00